Groundbreaking Discovery: Researchers Unveil Common Genetic Disorder May Affect Thousands

Thursday 11 July 2024 - 15:00

In a remarkable scientific breakthrough, researchers have uncovered a previously unknown genetic disorder that is estimated to impact hundreds of thousands of individuals around the world. The disorder, characterized by severe developmental delays and distinctive facial features, has been identified in numerous patients across the UK, Europe, and the United States.

The discovery was made by an international research collaboration led by Nicola Whiffin, an associate professor at the Big Data Institute and Centre for Human Genetics at the University of Oxford. Whiffin and her team analyzed the complete genomes of nearly 9,000 individuals with undiagnosed neurodevelopmental disorders (NDDs). Surprisingly, they found that dozens of these patients had mutations in the same gene, RNU4-2, which is not involved in protein production.

"It's not unusual to discover a neurodevelopmental disorder, but it is incredibly unusual to discover one that is this common," Whiffin said. Estimates suggest that mutations in the RNU4-2 gene may account for nearly 0.5% of all neurodevelopmental disorders globally, a significant proportion that translates to hundreds of thousands of affected individuals.

The disorder typically presents with severe developmental delays, an inability to speak, the need for tube feeding, and seizures. Patients also exhibit distinctive facial characteristics, such as large cupped ears, full cheeks, and downturned mouth corners.

"We know of hundreds of patients, but one of the key issues is that we are limited to making diagnoses in patients where we have their whole genome," Whiffin explained. Decoding entire genetic sequences has become more common in the UK and other developed countries, but many nations still lack the resources to conduct such extensive genetic testing.

One potential solution is the use of artificial intelligence (AI) tools to recognize the disorder based on facial features alone. If successful, this approach could allow doctors to diagnose the condition by simply uploading a patient's portrait for analysis, potentially expanding access to diagnosis worldwide.

The discovery of this genetic disorder has brought hope and relief to families who have long been searching for answers. Nicole Cedor, the mother of a 10-year-old girl with the disorder, expressed her gratitude for the research teams' efforts.

"We resigned ourselves to the fact that we may never find out. So, you can imagine our shock to get this news," Cedor said. "We are so grateful to each person on the research teams that worked tirelessly to find this diagnosis. It is one thing to write papers and crunch all that data, then another to see a family with a precious unique child who is living it day by day. This is where the data meets real life."

The identification of the RNU4-2 gene as the underlying cause of this disorder paves the way for further research and potential therapies. Whiffin noted that the discovery opens the door to exploring genome-targeted treatments that could improve the quality of life for those affected, such as interventions to address seizures.

"We are at a really exciting point where we have all these genome-targeted therapies," Whiffin said. "There's a question around whether we can make much difference to something that is so developmental, but perhaps we can do something to improve the seizures, to improve quality of life. This at least opens the door to trying those things."

The scientific community has welcomed this groundbreaking discovery, with researchers around the world collaborating to identify and support affected families. Dr. Anne O'Donell-Luria, co-director of the Center for Mendelian Genomics at the Broad Institute of MIT and Harvard, has already identified more than 10 families affected by the disorder after being informed of Whiffin's findings.

"As we reached out to other collaborating researchers, they also identified an unprecedented number of diagnoses including from many patients and families who have long been seeking answers," O'Donnell-Luria said. "Not having a diagnosis or an explanation for why the medical problems are occurring leaves patients and their families without a community, not knowing what other complications might be coming, and unable to know what steps to take next."

This discovery represents a significant step forward in understanding the genetic basis of neurodevelopmental disorders, offering hope and a research path towards potential therapies for those affected by this newly identified condition.